CVS Health (CVS) Tops Q1 EPS by 36c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $104.34 -0.31%
EPS Growth %: +1.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +1.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.57, $0.36 better than the analyst estimate of $2.21. Revenue for the quarter came in at $100.4 billion versus the consensus estimate of $95.02 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.30-$7.50, versus the consensus of $7.16.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TEN Holdings prices $7.5 million common stock offering at $1 per share
- TNL Mediagene faces Nasdaq delisting over bid price and equity rules
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
